Screening for Type 2 Diabetes > Cost-Effectiveness Author: Lorraine Lipscombe, MD, FRCPC; Denice S. Feig, MD, MSc, FRCPC
Editorial changes - 2009-05-01
Author information and module status
Key Points
Population at Risk
Effectiveness/Harms of Screening Tests
Effectiveness/Harms of Early Treatment
Direct Evidence that Screening Reduces Adverse Outcomes
Timeline
Cost-Effectiveness
Patient Education
Referral/Consultation
Guidelines
Tables
References
Glossary
What's New
Patient Information
Additional Resources
Tools
Recommendation
Appreciate that the benefits of screening for type 2 diabetes depend largely on the baseline CVD risk and that the benefits may outweigh the harms for persons with a 10-year CVD risk of over 8% to 10%.B

Evidence:

  • A decision analysis found that screening for type 2 diabetes in patients between the ages of 45 to 60 years using an FBG test was associated with a savings of 10 QALYs for every 10,000 individuals screened, with a gain of 4 QALYs from postponed microvascular complications and 17 QALYs from avoided CVD events. Furthermore, the benefit of screening depended largely on the baseline CVD risk, with the benefits outweighing the harms of screening for patients with a 10-year risk over 8% (41).

Comments:

  • None.

FAQs
Denice S. Feig, MD, MSc, FRCPC has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Lorraine Lipscombe, MD, FRCPC has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Sonal Singh, MD, editorial consultant, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott.

The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.